The role of microRNAs in Epstein-Barr virus latency and lytic reactivation
- PMID: 21835261
- PMCID: PMC4911174
- DOI: 10.1016/j.micinf.2011.07.007
The role of microRNAs in Epstein-Barr virus latency and lytic reactivation
Abstract
Oncogenic viruses reprogram host gene expression driving proliferation, ensuring survival, and evading the immune response. The recent appreciation of microRNAs (miRNAs) as small non-coding RNAs that broadly regulate gene expression has provided new insight into this complex scheme of host control. This review highlights the role of viral and cellular miRNAs during the latent and lytic phases of the EBV life cycle.
Copyright © 2011 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
Figures
References
-
- Garzon R, Calin GA, Croce CM. MicroRNAs in Cancer. Annu. Rev. Med. 2009;60:167–179. - PubMed
-
- Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120:15–20. - PubMed
-
- Kieff E, Rickinson A. Epstein-Barr virus and its replication. In: Knipe DM, Howley PM, editors. Fields Virology. Philadelphia: Lippincott, Williams, and Wilkins; 2006. pp. 2603–2654.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
